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In 1993, the World Health Organization (WHO) declared tuberculosis (TB) a global emer-
gency, and subsequently introduced the directly observed therapy short course (DOTS)
strategy, a technical and management package, based on the earlier work of the Interna-
tional Union Against Tuberculosis and Lung Disease (IUATLD) and international experience
with DOTS, which strategy beyond a doubt has played a great role in the initial success of
this program, especially in hospitalized patients under the initial intensive phase of 4-drug,
anti-TB treatment with Isoniazid, Rifampicin, Pyrazinamide and Ethambutol. This results
in rapid clinical well-being and early sputum conversion. This is indeed epidemiologically
very important to break the chain of infection. Despite successful implementation of most
of the elements of this strategy in several African countries and settings, TB case rates con-
tinue to escalate where the prevalence of HIV infection is high. There are also various other
reasons which render the patients defaulter. Non-compliance is not only detrimental to the
defaulters themselves as seen in this case study, but overall exposes the community to
increased risk. Development of acquired resistance is more common in these patients,
which makes their management very difficult. Therefore, it is important to anticipate those
at risk of being defaulters and make them adhere to anti-TB treatment. It is very rare to
trace and know what happened to a defaulter after he or she has dropped out, especially
after migrating from one place to another, in the absence of any documentation.
The following study is based on the story of a recurrent defaulter, a 64-year-old Saudi
male who was admitted on 27 July 2011 to SBAH-City Rehabilitation Hospital & Medical
Centre, Riyadh, Saudi Arabia.
 2012 Asian-African Society for Mycobacteriology. All rights reserved.-African Society for Mycobacteriology. All rights reserved.
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Introduction
The implementation of directly observed therapy short course
(DOTS) by the WHO in 1993 has indeed been very successful
and cost-effective [1]. One major achievement of DOTS since
its implementation has been its apparent ability to limit the
development and spread of acquired drug resistance. Some
of the known risk factors for non-compliance or non-adher-
ence to treatment under DOTS are alcoholism, intravenous
drug use, immigration, and homelessness in urban areas,
especially in developed countries [2,3], whereas illiteracy, pov-
erty, male gender, social stigmas, distance to TB clinics and
non-availability of a continuous supply of anti-TB drugs are
the factors more commonly encountered in underdeveloped
countries [4–8]. Substance abuse and psychological factors
as causes of non-compliance are common to all societies
[9]. One of the preventable factors responsible for the failure
of DOTS is non-compliance and drop out. It is more common
at the outpatient department (OPD) level during the continu-
ation phase of anti-TB treatment, whereas defaulters have in-
creased morbidity and mortality. They pose a potential threat
to the community as well. Acquired resistance is another con-
sequence of non-compliance, which makes the management
of these cases very challenging [10]. Therefore, the problem of
non-compliance needs to be taken very seriously.Fig. 1 – Chest X-ray PA view.Case report
A 64-year-old Saudi male patient presented to the Physiatry
clinic with the inability to stand or walk, bedridden, depen-
dent on others for activities of daily living (ADL), double
incontinent with an indwelling Foley’s catheter for retention
of urine since 2006, cachectic (severe generalized muscle
wasting, especially of the lower extremities) and loss of appe-
tite. He was admitted for rehabilitation. Admitting diagnosis
in Physiatry clinic was Diabetic-type-2, hypertension, bedrid-
den, dependent on others for ADL owing to paraparesis
Asian-B, normal upper limbs, lower limbs power 1+/5, double
incontinent; non-specific spondylitis s/p corrective surgery
for fusion of D-5, 6 vertebrae.
History
At the time of admission and examination, the patient was
fully alert and oriented lying in the bed; he gave a personal
history of suffering from type-2 diabetes and hypertension
for more than 15 years. He complains of severe anorexia,
chronic backache for many years with progressive general-
ized wasting, difficulty in standing and walking. He lost con-
trol of urinary bladder and bowels. Weakness of lower limbs
increased to the extent that he became bedridden and depen-
dent on others for ADL. He was brought in and admitted for
rehabilitation on 27 July 2011. At the age of 45 years (1992)
when he was residing in Jeddah, he gave a history of cough,
fever, expectoration, and blood-stained sputum. He was
admitted to the Tuberculosis and Chest Diseases hospital in
Taif where he was diagnosed as having open pulmonary TB
and was started on anti-TB treatment. He completed abouttwo months of treatment in the hospital. After being dis-
plan and only completed about 10 weeks of treatment.
According to the patient while in Jeddah, it was difficult for
him to travel to Taif to collect treatment owing to his busy
job as a soldier. After being discharged from the hospital, he
was feeling well and misconceived his wellness with being
cured. Soon after that he was transferred to a distant place,
in the north of Saudi Arabia where he is currently residing.
He always tried to hide his illness from his colleagues and rel-
atives, on the one hand as an attempt to save his job, and on
the other hand to avoid social segregation.
In 2006 he was hospitalized with the complaints of chronic
backache, progressive weakness of his lower extremities and
deteriorating bladder and bowel control. He was diagnosed as
having Pott’s disease affecting D4, 5, and 6 vertebrae, with
paraparesis; no microbiological or histological evidence was
available. A corrective surgery was performed on the thoracic
spine in a major hospital in Tabuk (Figs. 1 and 2), and the pa-
tient was started on anti-TB treatment. Unfortunately, once
again he failed to follow-up, and he did not continue anti-
TB treatment. According to his elder son, he defaulted just
after about 6 weeks of treatment due to severe anorexia, nau-
sea and vomiting. Despite his son’s personal efforts, the pa-
tient refused to take anti-TB drugs. The patient has been
treated many times for recurrent urinary tract infections over
the years owing to an indwelling Foley’s catheter since 2006.
Fig. 2 – Chest X-ray lateral view.
Fig. 3 – Discharging sinus.
Fig. 4 – Pus sample, AFB+ve.
Fig. 5 – Bisected penile meatus.
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and he is a smoker; he has no other addictions or any high
risk behavior; all his family members (spouse and children)
are clinically healthy. He remembers while living in Jeddah
that his mother was suffering from diabetes and was diag-
nosed with open pulmonary TB; she died as a result of mas-
sive haemoptysis while on treatment with anti-TB drugs.
Examination
The patient was bedridden, not in any distress, but looking
frail, pallor +, with diapers and indwelling Foley’s catheter.
Blood Pressure (BP) = 135/90 mmHg, heart rate (HR) = 102,
Temperature = 37.5 C, Oxygen Saturation (O2 SAT) = 97% at
room temperature; Weight = 42.2 kg, and body mass index
(BMI) = 19.
There was an old surgical scar on his back at the mid-tho-
racic region, mild tracheal shift towards left side. On auscul-
tation, he had reduced breath sounds on the left side.
Patient denied at this time any respiratory complaints. Chest
X-rays were suggestive of post-TB residual changes, espe-
cially on the left side with volume loss, while there were very
minimal fibrotic changes with compensatory hyper-expan-
sion of the right lung. Metal support and nails used in the cor-
rective surgery for thoracic vertebrae are also visible in the
chest X-rays (Figs. 1 and 2). Cardiovascular and abdominal
system was normal. A Foley’s catheter in situ, a healed sinus
on the right epididymis, a discharging sinus at the top of a
cold abscess 2 · 1.2 cm present at the proximal ventral aspectof the para-penile urethra. There was no evidence of penile
urethral fistulae. The penile meatus was bisected on ventral
aspect by about 1.5 cm ragged by chronic indwelling Foley’s
catheter. On neurological examination, upper limbs were nor-
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extremities with 1+/5 power, obvious in Figs. 3–5.
Investigations
Drained pus from the penile sinus tested positive for acid-fast
bacilli (AFB) on direct smear Ziehl–Neelsen (ZN) staining. Pus
C/S AFB was reported negative at 6 weeks, awaiting final
report. Sputum AFB direct smear negative, WBC = 5.22,
RBC = 2.4 Hb = 7.09 MCH = 26 MCV = 72 PLT = 460 ESR = 55,
S.iron = low, S.ferritin = low, blood group = A+ve, PPD = 14mm,
urine c/s Escherichia coli sensitive to ciprofloxacin and amika-
cin, TP. = 61, S.ALB = 28.5, AST = 9, ALT = 10, ALP = 157, T.bil =
NL, Hb A1c = 8.4, BUN = 11.9, Scr = 153, NA = 134, K = 5, ACTH
and Cortisol = NL.
Final diagnosis, treatment and course in the hospital
Recurrent defaulter, old partially treated pulmonary TB with
residual lung parenchymal changes, especially on the left
side, type-2 diabetes mellitus, hypertension, anemia, multifo-
cal active extra-pulmonary TB involving thoracic vertebrae 5
and 6 (Pott’s disease) s/p fusion surgery with spastic parapare-
sis, bedridden, double incontinence, active TB of the urogen-
ital system (AFB+ve cold abscess at the ventral penile shaft
with discharging sinus), Renal insufficiency and recurrent
UTI.
He was treated with (1) Mixtard insulin (70/30) Sc, 28 iu AM
and 12 iu PM. (2) Tab.diovan 300 mg PO OD. (3) Tab.ciprofloxa-
cin 500 mg PO BID. (4) Tab.INH 250 mg PO OD. (5) Tab.rifampi-
cin 450 mg PO OD. (6) Tab.pyrazinamide 800 mg PO OD. (7)
Tab.Ethambutol 600 mg PO OD. (8) Tab.Vit B6 40 mg PO OD.
(9) Syp.Ferose 150 mg PO OD; he received two units of pack
RBCs.
In the light of final diagnosis, his condition and co-morbid-
ities with prognosis were discussed in the team conference
with the patient and his elder son. The patient and his care-
giver (elder son) were educated about the necessity of pro-
longed un-interrupted anti-TB treatment and regular follow-
up. They were reminded about the grave consequences of
being non-compliant in the past, and were made aware and
sensitized to the possible dangers and consequences of future
defaulting. The patient was declared too sick to be given any
kind of rehabilitation by the multidisciplinary team at this
stage except for caregiver education. Subsequently, he was
transferred to an acute care infectious diseases hospital on
17 August 2011.
Discussion
In the history of TB treatment, various landmark studies on
short-term anti-TB treatment like BMRC-Hong Kong chest
service 1978; BTA UK-France study (22) 1980; BMRC-Singapore
study-1981; BTA 1981; and Lahore Short-term TB Study PMRC-
1988 was indeed a great step towards, better compliance, bet-
ter outcomes and cost-effectiveness [11–13]. The next
remarkable step in this direction was taken by WHO in 1993
with the declaration of global emergency and the introduc-
tion of DOTS strategy. Both the HIV epidemic in South Africaand the worldwide variable non-compliance owing to various
reasons has adversely affected the DOTS strategy.
TB is a chronic disease; a patient-oriented permanent
NTBCP is therefore a basic requirement of every country
and region of the world. In the Kingdom of Saudi Arabia,
NTBCP has been implemented in phases since 1970. The
DOTS strategy was adopted in the early 1990s. It includes an
initial intensive phase of 2 months with a 4-drug combination
(2H + 2R + 2PZA + 2E) and 4 months with 4H + 4R. Its aim is (1)
to decrease the incidence of sputum-positive TB in Saudi Ara-
bia to 1/100,000 by the year 2010; (2) To increase the case
detection of smear-positive patients to more than 85–90% by
the year 2005; and (3) To increase a cure rate of 90% by the
year 2005 [14].
DOTS alone cannot be successful until a preventable ele-
ment of non-compliance is taken and tackled seriously. In
the existing literature, non-compliance is defined as one or
more of the following:
(1) missing >2 consecutive weeks of DOTS; or
(2) prolongation of treatment >30 days due to sporadic
missed doses; or
(3) poor outcome of therapy, defined as a microbiologic or
clinical failure of initial therapy resulting in morbidity,
relapse, or death owing to TB in defaulters (who miss
two consecutive months of DOTS) [2].
Non-compliance is a universal problem, faced both in
developed as well as under developed countries. Various risk
factors and reasons associated with non-compliance men-
tioned in old and present literature are as follows: Non-moti-
vation during the early phase of treatment, alcoholism, IV
drug use, homelessness, male gender, work-related issues,
social stigma, illiteracy, long distance to DOTS centre, early
freedom from symptomsmisconceived as being cured, migra-
tion, drug-related toxicity, non-availability of supply of anti-
TB drugs, lack of central registry for recording, reporting
and organized transfer of patients from one DOTS centre to
another [2–10].
The subject patient was diagnosed the first time with open
pulmonary TB at the age of 45 years in 1992; he defaulted after
10 weeks of treatment; the second time he was diagnosed as
having Pott’s disease involving the thoracic spinewith parapa-
resis at the age of 59 years in 2006; he defaulted again just after
6 weeks of anti-TB treatment. And now, the last time at the age
of 64 years in 2011 hewas diagnosed in the researchers’ hospi-
tal with active extra-pulmonary TB of the urogenital system.
Some of the factors making the subject patient a recurrent de-
faulter and non-compliant were just the same as mentioned
above in various studies on this subject: a male gender, con-
scious of social stigma, with a low education level, having
job-related issues, who misconceived early improvement as
being cured when treated the first time for open pulmonary
TB in 1992. According to the patient, the long distance between
his residence in Jeddah to theDOTS centre in Taifwas inconve-
nient for him. At the same time he was transferred and there
wasmigration of residence to Tabuk region in thenorth of Sau-
di Arabia. Finally, during the second course of anti-TB treat-
ment started for Pott’s disease and paraparesis in 2006, he
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drugs. Defaulters not only increased morbidity and mortality,
but are also a source of acquired resistance, whichmakes their
management very challenging. The community at large is also
faced with increased risk. In one of the recent studies in Wes-
tern Turkey, regarding the risk factors for acquiredmycobacte-
rial resistance on 214 patients, the figures for total rates related
to streptomycin, isoniazid, rifampicin, ethambutol and Isonia-
zid + Rifampicin are quoted as 29.0%, 27.1%, 21.5%, 10.3% and
11.6%, respectively. Secondary rates for all drugs and combina-
tions were 15 times higher in non-compliant patients under
treatment; inadequate regimens and non-compliance in-
creases the chances of secondary resistance by 10.5 times [15].Conclusion and recommendations
The issue of non-compliance therefore needs to be redressed
on a priority basis to ensure adherence to TB treatment. There
is an urgent need for early motivation and health education of
the patients. Well-organized social services able to reach pa-
tients at their doorsteps need to be an integral part of the pa-
tient-oriented DOTS program. There is a need for improved
central registry, for organized recording, reporting, and trans-
fer of patients between various regional DOTS centres. Slot-
ting system of treatment cards according to appointment
dates and calling system for those not attending has special
importance. It is equally important during the initial inten-
sive phase, as well as during the continuation phase, because
the dropout rate is more frequent during the continuation
phase. Special attention should be focused on those with a
risk of defaulting. An experienced and well-trained team is
mandatory for better case management. Maintaining a cor-
rect contact address to trace and approach those who fail to
attend on the day of their appointment will be a step in the
right direction. TB is a chronic disease, therefore there is an
urgent need to establish a patient-oriented permanent NTBCP
in every country or region of the world. Last, but not the least,
there is a need for a continued campaign to educate the
masses by electronic and print media. Because treatment of
one saves ten, no one is safe until everybody is safe.
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